Purified forms of rofecoxib, methods of manufacture and use
US11617735B2 · kind B2 · utility
1Cited by
26References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2022 |
| Grant date | Apr 4, 2023 |
| Priority date | — |
| Expiry date | Jun 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.